Literature DB >> 25600703

Four types of ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery: classification of IBTR based on precise pathological examination.

Takehiko Sakai1, Seiichiro Nishimura, Akiko Ogiya, Masahiko Tanabe, Kiyomi Kimura, Hidetomo Morizono, Kotaro Iijima, Yumi Miyagi, Masujiro Makita, Yoshinori Ito, Masahiko Oguchi, Rie Horii, Futoshi Akiyama, Takuji Iwase.   

Abstract

We classified ipsilateral breast tumor recurrences (IBTRs) based on strict pathological rules. Ninety-six women who were surgically treated for IBTR were included. IBTRs were classified according to their origins and were distinguished based on strict pathological rules: relationship between the IBTR and the primary lumpectomy scar, surgical margin status of the primary cancer, and the presence of in situ lesions of IBTR. The prognosis of these subgroups were compared to that of new primary tumors (NP) in the narrow sense (NPn) that occurred far from the scar. Distant-disease free survival of IBTR that occurred close to the scar with in situ lesions and a negative surgical margin of the primary cancer (NP occurred close to the scar, NPcs) was similar to that of NPn. In contrast, IBTR that occurred close to the scar without in situ lesions (true recurrence (TR) that arose from residual invasive carcinoma foci, TRinv) had significantly poorer prognosis than NPn. IBTR that occurred close to the scar with in situ lesions and a positive surgical margin of the primary cancer (TR arising from a residual in situ lesion, TRis) had more late recurrences than NPcs. Precise pathological examinations indicated four distinct IBTR subtypes with different characteristics.
© 2015 Japanese Society of Pathology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  breast cancer; breast-conserving surgery; ipsilateral breast tumor recurrence; new primary tumor; true recurrence

Mesh:

Year:  2015        PMID: 25600703     DOI: 10.1111/pin.12253

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  2 in total

1.  Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy.

Authors:  James Laird; Benjamin Lok; Chun Siu; Oren Cahlon; Atif J Khan; Beryl McCormick; Simon N Powell; Hiram Cody; Hannah Yong Wen; Alice Ho; Lior Z Braunstein
Journal:  Ann Surg Oncol       Date:  2017-11-01       Impact factor: 5.344

2.  Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma.

Authors:  Jun-Hee Lee; Hyunjun Lee; Yoon Ju Bang; Jai Min Ryu; Se Kyung Lee; Jonghan Yu; Jeong Eon Lee; Seok Won Kim; Seok Jin Nam; Byung Joo Chae
Journal:  J Breast Cancer       Date:  2022-08       Impact factor: 2.922

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.